BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26607501)

  • 1. A promising hypothesis of c-KIT methylation/ expression paradox in c-KIT (+) squamous cell carcinoma of uterine cervix ----- CTCF transcriptional repressor regulates c-KIT proto-oncogene expression.
    Chang SW; Chao WR; Ruan A; Wang PH; Lin JC; Han CP
    Diagn Pathol; 2015 Nov; 10():207. PubMed ID: 26607501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual c-KIT+ squamous cell carcinoma of the uterine cervix showing paradoxical hypermethylation of the c-KIT proto-oncogene.
    Chao WR; Lin WL; Chen CK; Han LM; Lin JC; Han CP
    Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():130-1. PubMed ID: 25524714
    [No Abstract]   [Full Text] [Related]  

  • 3. Overexpression of c-KIT (CD117) occurs infrequently in squamous cell carcinoma of the uterine cervix.
    Han CP; Lin WL; Wang PH; Yang SF; Lewis JS; Chen CK; Ruan A; Kuo JF; Lee MY; Chiang H
    Histopathology; 2011 May; 58(6):988-90. PubMed ID: 21585433
    [No Abstract]   [Full Text] [Related]  

  • 4. Unusual c-KIT (+) squamous cell carcinoma of uterine cervix showing remarkable platelet-derived growth factor receptor, alpha subunit expression, but no activating mutation.
    Han CP; Chen CK; Lin CK; Wang PH; Chiang H
    Histopathology; 2011 Oct; 59(4):788-90. PubMed ID: 22014059
    [No Abstract]   [Full Text] [Related]  

  • 5. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of human riboflavin transporter 2(hRFT2) in cervical cancers from Uighur women.
    Ma JQ; Kurban S; Zhao JD; Li QZ; Hasimu A
    Asian Pac J Cancer Prev; 2014; 15(6):2485-9. PubMed ID: 24761851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation-free expression of c-Kit proto-oncogene in primary adenocarcinoma of uterine cervix.
    Chao WR; Chen CK; Han LM; Han CP
    Taiwan J Obstet Gynecol; 2016 Oct; 55(5):741-742. PubMed ID: 27751428
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular profiling of c-KIT oncogene in high grade neuroendocrine carcinoma of the uterine cervix: Analysis of twelve cases.
    Tsai WC; Chen CK; Han CP; Chao WR
    Taiwan J Obstet Gynecol; 2019 Jul; 58(4):581-582. PubMed ID: 31307758
    [No Abstract]   [Full Text] [Related]  

  • 9. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix.
    Dong SM; Kim HS; Rha SH; Sidransky D
    Clin Cancer Res; 2001 Jul; 7(7):1982-6. PubMed ID: 11448914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of gene mutations in KIT-positive thymic epithelial tumors.
    Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
    Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of aquaporin-8 and bcl-2 protein in human cervical carcinoma and their correlations].
    Yao JF; Zhou CY; Wei LF; Wang SY; Shi YF
    Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):205-8. PubMed ID: 18788571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of c-KIT expression in breast cancer correlates with malignant transformation of breast epithelium and is mediated by KIT gene promoter DNA hypermethylation.
    Janostiak R; Vyas M; Cicek AF; Wajapeyee N; Harigopal M
    Exp Mol Pathol; 2018 Aug; 105(1):41-49. PubMed ID: 29852185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma.
    Kang S; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM
    Gynecol Oncol; 2007 Jun; 105(3):662-6. PubMed ID: 17360030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops.
    Martinho O; Gonçalves A; Moreira MA; Ribeiro LF; Queiroz GS; Schmitt FC; Reis RM; Longatto-Filho A
    Gynecol Oncol; 2008 Nov; 111(2):350-5. PubMed ID: 18708242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-kit overexpression in neuroendocrine small cell carcinoma of the uterine cervix.
    Ohwada M; Wada T; Saga Y; Tsunoda S; Jobo T; Kuramoto H; Konno R; Suzuki M
    Eur J Gynaecol Oncol; 2006; 27(1):53-5. PubMed ID: 16550970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of gene mutations in KIT-positive carcinoma showing thymus-like elements of the thyroid.
    Pan Y; Zhao X; Yang J; Deng J; Zhan Z; Luo Y; Li Q; Guo Y; Zhai Q; Sun B
    Hum Pathol; 2012 Mar; 43(3):350-5. PubMed ID: 21835435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix.
    Chang JL; Tsao YP; Liu DW; Han CP; Lee WH; Chen SL
    Gynecol Oncol; 1999 Apr; 73(1):62-71. PubMed ID: 10094882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA hypomethylation of CAGE promotors in squamous cell carcinoma of uterine cervix.
    Lee TS; Kim JW; Kang GH; Park NH; Song YS; Kang SB; Lee HP
    Ann N Y Acad Sci; 2006 Dec; 1091():218-24. PubMed ID: 17341616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
    Ocadiz R; Sauceda R; Cruz M; Graef AM; Gariglio P
    Cancer Res; 1987 Aug; 47(15):4173-7. PubMed ID: 3300961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [p16 gene CpG methylation in cervical squamous cell carcinoma and HPV16 infection in Uyghur women].
    Yuan M; Li A; Yao L; Shen G; Cheng J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jan; 38(1):48-53. PubMed ID: 23406849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.